Metro North Hospital and Health Service (MNHHS) is seeking to establish a contract for Closed System Transfer Devices (CSTD). Offers must be submitted electronically via VendorPanel by 2:00 PM Queensland time on Wednesday, 24th June 2026. Offers must remain valid for 12 months. Mandatory requirements include ARTG certification, compliance with ISO **** and ISO ****, Niosh definition compliance, traceable UDI, sterile packaging evidence, microbial barrier/sterility maintenance, conforming insurance, and compliance with the Queensland Government Supplier Code of Conduct. Desirable criteria include sterile product marking, quantified residual/lost volume, disclosed limitations, product compatibility, tactile/audible/visual connection confirmation, compatibility with infusion pumps and automated compounding solutions, latex status, and a transition management plan. Samples will be requested from shortlisted suppliers for functional assessment. Price will be evaluated based on total cost for specific infusions and a price list for all products.
Offers must be lodged by 2:00 PM Queensland time on Wednesday, 24th June 2026.
The evaluation process includes mandatory pass/fail criteria, desirable criteria, clinical trial assessment of samples, and price. The evaluation process for this tender will include four stages as detailed below. Stage 1 Mandatory pass/fail. . . Stage 2 Desirable criteria. . . Stage 3 Clinical trial. . . Stage 4 Price.
All components proposed in the offer should hold ARTG certification. All relevant products and processes proposed in the offer must comply with ISO: **** and ISO: ****, certification to be provided. The products proposed in the offer must meet the NIOSH definition of a CSTD. Each component must have traceable UDI aligning to GS1 standards. Sterile components are to be supplied in uncompromised sterile packaging. Provide evidence of microbial barrier/sterility maintenance for 7 days or more under defined storage conditions and access frequency, when a vial adaptor remains in place. Evidence of conforming insurance documentation. Compliance with Queensland Government supplier code of conduct. Respond to all applicable sections of Part C ITO response schedules and attachments. Operable with personal protective equipment (double gloves in biological safety cabinet/isolator and at bedside, including footprint, dexterity and wipe down).
MNHHS will not be holding site visits for this opportunity.
Samples will be requested from shortlisted suppliers for a functional assessment by the evaluation panel. Samples will be requested from shortlisted suppliers for a functional assessment by the evaluation panel.
Closing date for information clarification questions is 2:00 PM Queensland time, 3 business days prior to the closing date and time of this invitation to offer, 19th June 2026.
Any suppliers response that has demonstrated a failure in capability or capacity to meet the customers requirements for any evaluation criterion, may be considered a nonconforming offer. Failure to comply with addenda requirements may result in the suppliers offer being excluded from further consideration.